Transdel Gives JH Direct Exclusive Rights to Transdel™

LA JOLLA, Calif.—Transdel Pharmaceuticals Inc. and JH Direct LLC have entered into a licensing agreement providing JH Direct with the exclusive worldwide rights to Transdel's anti-cellulite cosmeceutical product which utilizes Transdel's patented transdermal delivery system technology, Transdel™. The licensing agreement between Transdel and JH Direct is a significant milestone for Transdel, as it is the first agreement involving the use of Transdel's proprietary technology for a cosmeceutical product. Transdel plans to further develop its pipeline of cosmetic/cosmeceutical products.

Under the terms of the agreement, JH Direct will pay Transdel initial royalty advances and a continuing licensing royalty on the worldwide sales of the anti-cellulite product. The product will be launched through direct response television campaigns, created and managed by JH Direct, followed by an expansion into traditional channels of distribution, such as retail or wholesale channels. Transdel has retained the exclusive rights to seek pharmaceutical/dermatological partners for the anti-cellulite product for an initial period of one year, thereafter JH Direct will be allowed to expand in this channel.

“We are extremely pleased with our relationship with JH Direct and plan on building on this relationship to launch additional cosmeceutical products. This venture is very exciting as we believe it could represent the beginning of what may become a revenue stream for Transdel. An estimated 85 percent to 90 percent of women develop cellulite following puberty. The size of this target market combined with the desire to remove cellulite represents a $3 billion market and thus provides a promising market opportunity,” stated Dr. Juliet Singh, president and chief executive officer of Transdel. “We also plan on expanding our pipeline to include formulations for anti-aging, varicose vein and hyperpigmentation cosmetic/cosmeceutical products.”

Johann Verheem, JH Direct's chief executive officer, said: “We feel the anti-cellulite product provides a significant market opportunity for JH Direct. The use of Transdel's propriety transdermal delivery system in the product will make it unique and potentially more effective than other products currently on the market. We anticipate bringing this product to market rapidly and expanding our relationship with Transdel in other areas.”

var loc = window.location.pathname;var nt=String(Math.random()).substr(2,10);document.write ('');